FREMONT, CA, March 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire-- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ...
SILICON VALLEY, CA - June 26, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS ...
FREMONT, CA, March 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire-- ABVC BioPharma, Inc. (ABVC) (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback